National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
Provenge (PROH-venj)

 A vaccine made from immune system cells collected from a patient with prostate cancer. The cells are treated in the laboratory with a growth factor attached to a protein found on prostate cancer cells. Provenge injected into patients may stimulate T lymphocytes to kill tumor cells that express the prostate protein. Also called APC8015 and Sipuleucel-T.

Previous Definitions:protocol, proton, proton beam radiation therapy, proton magnetic resonance spectroscopic imaging, protozoal
Next Definitions:proximal, Proxinium, pruritus, PS-341, PSA